2026 Regular Session
HB1426
Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Establishing a clinical research pharmacy permit; authorizing the State Board of Pharmacy to issue a clinical research pharmacy permit; authorizing a health care provider to hold an ownership interest in a clinical research pharmacy under certain circumstances; prohibiting an individual from being required to obtain a license, certification, or authorization to practice under certain provision of law to own or have an ownership interest in a clinical research pharmacy; etc.
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Recorded floor votes
1 roll call are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
April 13, 2026 · House
Third Reading Passed
Passed ⭐ Substantive final action
129 yea–5 nay · 6 not voting · 1 absent
Committee referrals
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
Senate Referred Rules
-
House Third Reading Passed (129-5) View roll call
-
House Second Reading Passed with Amendments View roll call
-
House Favorable with Amendments {243720/1 Adopted View roll call
-
House Favorable with Amendments Report by Health
-
House Hearing 3/05 at 1:00 p.m.
-
House First Reading Health